Grifols A : Steven F. Mayer resigns as Executive Chairman due to health reasons
>Resignation of Steven F. Mayer as Executive Chairman and director of the Board - Steven F. Mayer has resigned as Executive Chairman and director of Grifols’ Board of Directors due to health and other personal reasons by means of a letter addressed to the Board, effective 21 February.Appointment of Thomas Glanzmann as new Executive Chairman - The Board of Directors has unanimously resolved to appoint Thomas Glanzmann as Executive Chairman, effective ...Grifols is engaged in developing, manufacturing and distributing a range of plasma derivative products. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend the lives of individuals who suffer from chronic and acute conditions. Co. also specializes in providing infusion solutions, nutrition products, medical devices, diagnostic instrumentation and reagents for use in hospitals and clinics. Co.'s products and services are used by healthcare providers in approximately 100 countries. Co.'s business is organized into three divisions: Bioscience, Diagnostic, Hospital and Raw Materials.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.